EUCODIS Bioscience and Lohmann Animal Health Announce Achievement of Major Development Milestone
EUCODIS Bioscience, a company developing proteins for the chemical industry,
and Lohmann Animal Health (LAH), a company developing and marketing products
for animal nutrition and animal health, today announced the achievement of a
major development milestone in their collaboration agreement relating to the
optimization of an undisclosed protein.
EUCODIS Bioscience has completed the development of the prototype protein
which is intended to be part of an innovative LAH product. This achievement
triggered a milestone payment to EUCODIS Bioscience from LAH. The development
project has moved into its final phase, with LAH testing the protein in the
“The achievement of this milestone underlines the capacity of EUCODIS
Bioscience to develop enzymes and other proteins for different industrial
with the upcoming launch of our first commercial enzyme, this achievement
further fuels our efforts to aggressively expand our current European focus
into the US and Asian markets.”
“We are pleased to work with a development partner such as EUCODIS
Bioscience that combines industrial discipline with a versatile and proven
technology”, said Dr.
protein know-how and development expertise improves the R&D efficiency of LAH
and helps us to provide superior products to our customers”.
About Lohmann Animal Health
Lohmann Animal Health (LAH) is a leading provider of feed components and
vaccines for farm animals, contributing to a safe food supply. Based in
of its revenues generated from export sales. The Company has more than 500
sales offices in over 30 countries.
As European market leader LAH offers a wide variety of proven and
innovative products in the Feed Additives segment. They range from amino
acids and antioxidants to flavors and colorants to probiotics and enzymes.
LAH also offers the entire spectrum of vitamins and provitamins, including
beta-carotene, as well as specialties such as L-carnitine and botanicals.
For more information, please visit http://www.lah.de
About EUCODIS Bioscience
EUCODIS Bioscience GmbH develops enzymes and other proteins and related
biocatalytic processes that enable the chemical, pharmaceutical and other
industries to establish critical manufacturing processes and to generate
Based on its proven proprietary technology and led by an experienced
management team, EUCODIS Bioscience provides products and services that help
its customers to improve efficiencies and to meet growing environmental
The Company commercializes its enzyme expertise and its versatile and
powerful technology in development projects with industrial partners. Current
partners include industry leaders such as GlaxoSmithKline, Henkel, and
Lohmann Animal Health.
The Company was founded in 2007, as a demerger of the “white biotech”
business unit of Eucodis GmbH, a company founded in 2004. The Company is
For more information, please visit http://www.eucodisbioscience.com Contact Lohmann Animal Health: Dr. Roland Boerner Head of Corporate Communications Lohmann Animal Health GmbH & Co KG Heinz-Lohmann-Strasse 4 D-27472 Cuxhaven Germany +49-4721-747-424 Roland.Boerner@lah.de Company contact EUCODIS Bioscience: Rudy Pandjaitan, PhD CEO EUCODIS Bioscience Brunner Strasse 59 A-1230 Vienna AUSTRIA +43-1-86634-9241 firstname.lastname@example.org Media contact EUCODIS Bioscience: Frank Butschbacher Investor Relations & Communications http://www.butschbacher.net +43-650-7844940 email@example.com
SOURCE EUCODIS Bioscience